hepat
e
viru
hev
emerg
caus
viral
hepat
worldwid
recent
shown
infect
camel
human
studi
hev
seropreval
dromedari
camel
among
bedouin
arab
muslim
nonebedouin
jew
assess
factor
associ
antihev
seroposit
serum
sampl
dromedari
camel
n
use
determin
camel
antihev
igg
hev
rna
posit
human
sampl
collect
year
old
bedouin
n
nonbedouin
arab
n
jew
n
randomli
select
use
agestratifi
sampl
design
human
hev
igg
level
determin
use
wantai
igg
elisa
assay
sampl
obtain
camel
antihev
posit
among
human
popul
bedouin
nonbedouin
arab
significantli
higher
preval
hev
antibodi
respect
compar
jewish
popul
seroposit
increas
significantli
age
human
popul
reach
among
year
old
bedouin
nonbedouin
arab
respect
high
seroposit
camel
year
old
bedouin
nonbedouin
arab
suggest
hev
endem
israel
low
hev
seropreval
jew
could
attribut
higher
socioeconom
statu
hepat
e
viru
hev
emerg
pathogen
one
caus
viral
hepat
world
infect
mostli
silent
symptom
appear
ill
usual
selflimit
hev
infect
also
becom
chronic
immunocompromis
individu
receiv
organ
transplant
chemotherapi
well
among
individu
hiv
infect
moreov
extra
hepat
manifest
hev
infect
mostli
neurolog
increasingli
recognis
current
eight
hev
genotyp
known
belong
singl
serotyp
identifi
dromedari
bactrian
camel
respect
identifi
liver
transplant
recipi
link
consumpt
camel
product
human
hev
infect
investig
use
seropreval
studi
found
preval
older
age
lower
socioeconom
statu
poorer
resid
area
among
shelter
homeless
adult
uneduc
peopl
specif
nation
exampl
higher
mix
race
donor
ethnic
group
within
china
immigr
afghanistan
drink
water
well
river
consumpt
meat
product
especi
pork
follow
blood
transfus
major
popul
israel
compris
jew
arab
muslim
almost
israeliarab
born
israel
jew
compos
mix
popul
israeliborn
nonisraeliborn
individu
previous
shown
overal
hev
seropreval
israel
higher
arab
compar
jew
antihev
posit
jew
immigr
born
israel
howev
assess
antihev
preval
specif
subgroup
arab
done
bedouin
israel
compos
uniqu
nomad
muslim
arab
popul
cultur
histor
social
uniqu
nonbedouin
muslim
arab
live
villag
spread
around
countri
mostli
northern
central
part
israel
physic
relat
camel
mani
bedouin
live
southern
israel
dromedari
camel
consum
camel
product
studi
aim
assess
hev
seropreval
camel
dromedari
bedouin
live
southern
part
israel
vicin
camel
nonbedouin
arab
muslim
live
northern
central
israel
israeliborn
jew
assess
factor
associ
antihev
seroposit
camel
serum
sampl
n
femal
dromedari
camel
age
n
n
year
n
collect
bedouin
household
resid
southern
district
israel
part
middl
east
respiratori
syndrom
mer
nation
control
programm
use
determin
hev
seropreval
local
camel
human
serum
sampl
collect
bedouin
live
southern
district
tribe
dromedari
camel
overal
test
first
time
studi
nine
ad
previou
studi
nonbedouin
arab
overal
present
studi
previou
studi
jew
sampl
present
previou
studi
human
sampl
randomli
select
use
agestratifi
sampl
design
store
sera
bank
isra
centr
diseas
control
sampl
select
collect
year
old
born
israel
select
enabl
avail
basic
demograph
inform
includ
age
gender
place
resid
citi
birth
countri
popul
group
bedouin
nonbedouin
arab
jew
sampl
sera
bank
socioeconom
statu
alloc
basi
given
address
use
socioeconom
residenti
classif
publish
isra
central
bureau
statist
socioeconom
statu
base
variabl
includ
demograph
characterist
educ
lifestyl
etc
divid
low
vs
high
sera
collect
approv
legal
depart
isra
ministri
health
total
antihev
antibodi
assess
camel
sampl
use
hevab
elisa
kit
wantai
biolog
pharmaci
enterpris
beij
republ
china
detect
total
antibodi
suitabl
detect
anti
hev
antibodi
nonhuman
sera
hev
rna
camel
sera
assess
realstar
hev
kit
altona
diagnost
gmbh
hamburg
germani
accord
manufactur
detect
hev
genotyp
human
sampl
current
studi
test
antiigg
hev
elisa
kit
wantai
biolog
pharmaci
enterpris
beij
republ
china
recognis
human
antibodi
hev
genotyp
sensit
specif
assay
perform
accord
manufactur
instruct
serolog
equivoc
result
consid
neg
previou
studi
use
dsiantihevigg
kit
diagnost
system
itali
saronno
itali
merg
current
previou
studi
data
applic
compar
kit
perform
use
posit
neg
sampl
reveal
concord
kit
hev
rna
assess
human
sera
due
lack
suffici
serum
materi
descript
analysi
done
studi
popul
preval
rate
antihev
antibodi
camel
human
sera
calcul
divid
number
sampl
posit
antihev
antibodi
total
number
sampl
test
group
human
sampl
calcul
preval
rate
studi
popul
age
group
gender
socioeconom
statu
use
cochranarmitag
trend
test
evalu
trend
binomi
proport
test
compar
popul
group
logist
regress
analys
appli
assess
factor
associ
antihev
seroposit
interact
assess
variabl
associ
hev
seroposit
statist
signific
evalu
use
test
alpha
level
analys
perform
use
sa
enterpris
guid
version
sa
institut
inc
cari
nc
usa
sampl
obtain
camel
ci
antihev
igg
posit
seropreval
among
camel
year
old
sampl
obtain
nonbedouin
arab
ci
sampl
obtain
jew
ci
antihev
igg
posit
hev
seroposit
significantli
higher
bedouin
nonbedouin
arab
compar
jew
pvalu
differ
seroposit
rate
bedouin
nonbedouin
arab
statist
signific
pvalu
tabl
demonstr
odd
hev
posit
popul
group
demonstr
significantli
higher
odd
among
older
age
group
arab
popul
singl
variabl
analysi
demonstr
seroposit
significantli
higher
among
arab
bedouin
nonbedouin
older
age
group
year
lower
socioeconom
statu
tabl
signific
interact
identifi
associ
remain
statist
signific
multivari
analysi
except
lower
socioeconom
statu
tabl
sensit
analysi
perform
classif
equivoc
sampl
posit
neg
signific
differ
observ
hev
preval
among
dromedari
camel
studi
past
follow
literatur
review
realis
find
higher
seropreval
rate
report
ethiopia
similar
seroposit
among
dromedari
camel
recent
report
egypt
nearbi
countri
togeth
result
suggest
camel
region
highli
seroposit
hev
r
bassal
et
al
bedouin
nonbedouin
arab
characteris
significantli
higher
hev
seropreval
rate
compar
overal
low
seroposit
rate
observ
jew
togeth
high
seropreval
hev
camel
result
indic
endem
hev
israel
worldwid
seropreval
hev
document
human
popul
vari
high
medium
low
high
hev
seropreval
rate
report
uganda
poland
bolivia
jordan
south
africa
medium
hev
seropreval
rate
report
china
belgium
portug
mediterranean
region
low
hev
seropreval
rate
report
new
zealand
scotland
iceland
accordingli
within
israel
high
medium
low
hev
seropreval
rate
observ
bedouin
nonbedouin
arab
jew
higher
seropreval
rate
bedouin
could
attribut
low
socioeconom
statu
could
also
result
exposur
camel
especi
latter
highli
seropreval
possibl
consequ
infect
camel
sampl
hev
rna
neg
fecal
specimen
avail
analysi
hypothesi
could
explor
jordan
nearbi
countri
overal
antihev
preval
rate
determin
local
popul
own
camel
associ
increas
odd
hev
seroposit
futur
studi
aim
assess
hev
rna
preval
camel
fece
fresh
blood
sampl
well
similar
sampl
obtain
bedouin
camel
recent
report
suggest
hev
origin
asia
like
human
ancestor
exist
year
ago
split
camelinfect
genotyp
occur
camel
domest
hev
circul
camel
bedouin
could
expect
high
hev
seroposit
rate
observ
nonbedouin
arab
live
northern
part
israel
could
attribut
exposur
possibl
circul
countri
recent
identifi
local
sewag
facil
mainli
north
israel
judaism
islam
forbid
consumpt
pork
find
unlik
main
risk
identifi
hev
seropreval
muslim
popul
low
hev
seropreval
observ
israeliborn
jew
may
associ
overal
higher
socioeconom
statu
characteris
popul
live
better
sanitari
condit
bedouin
nonbedouin
arab
render
hev
infect
less
conceiv
variabl
observ
differ
popul
group
differ
studi
may
explain
exposur
potenti
risk
factor
associ
hev
infect
lifestyl
habit
dietari
environment
condit
geograph
locat
occup
religion
prohibit
consum
pork
among
jew
islam
also
comorbid
differ
may
also
explain
assay
use
antibodi
detect
demonstr
wide
variat
abil
detect
hev
antibodi
sensit
specif
associ
hev
seroposit
age
observ
studi
also
report
other
may
explain
cumul
lifetim
exposur
hev
also
cohort
effect
certain
popul
group
like
expos
viru
life
major
limit
studi
lack
data
characterist
might
import
exposur
hev
actual
exposur
anim
consumpt
camel
meat
qualiti
local
water
sourc
addit
crosssect
natur
data
establish
tempor
relationship
risk
factor
outcom
thu
limit
interpret
result
final
hev
rna
human
sampl
could
assess
due
limit
serum
volum
howev
first
time
investig
sampl
local
camel
specif
human
popul
fair
distribut
age
group
gender
base
cohort
result
suggest
hev
endem
israel
specif
popul
group
like
bedouin
nonbedouin
arab
higher
risk
hev
infect
studi
need
determin
hev
genotyp
circul
among
dromedari
camel
specif
arab
popul
author
orcid
r
bassal
